Mobile Data Corp. (MBYL.OB) Announces Availability of the MDC Tracker from Their Website
Yesterday, Mobile Data Corp. announced that the MDC Tracker will be available for download directly from their corporate website www.mobiledatacorp.com…
Blog
Kansas City Life Insurance Company (KCLI) Sees Ratings Affirmation from A.M. Best
Kansas City Life Insurance Company announced that after a review of the financial strength of the company, A.M. Best has…
Immunovaccine Inc. (IMV.V) Signs Research Agreement with Vaxil BioTherapeutics
Yesterday, representatives from Immunovaccine Inc. announced that the company has signed a collaborative research agreement with Vaxil BioTherapeutics. The research…
Pizza Inn, Inc. (PZZI) Announces New Development Agreement
Pizza Inn, Inc. recently announced a development agreement with one of its existing licensees to open an additional 44 Pizza…
Manas Petroleum Corp. (MNAP.OB) Subsidiary Completes Seismic Program
Manas Petroleum Corp. yesterday announced that its 90 percent-owned subsidiary CJSC Somon Oil (Somon) has completed its acquisition of a…
Players Network (PNTV.OB) Hits New 52-Week High Following Mention in QualityStocks Newsletter
Players Network closed today's trading at $0.32 a share, up 10.34% for the day. Earlier in the day, the stock…
Points International (PTSEF.OB) Expands Partnership with Amtrak Guest Rewards
Amtrak and Points International, proprietor of Points.com, the innovative global leader in online loyalty program management, announced expansion of the…
KACHING KACHING, Inc. (KCKC.OB) Launches New Website and Ticker Symbol
KACHING KACHING, Inc., the first-of-its-kind online retail chain which transforms licensees into actual storeowners able to deal directly with manufacturers/distributors,…
Biomoda, Inc. (BMOD.OB) Receives Patent in Mexico
One company this is starting to capture the attention of investors is Biomoda Inc. Located in Albuquerque, New Mexico, Biomoda…
Provectus Pharmaceuticals Inc. (PVCT.OB) Releases Updated Data for Clinical Trials of Melanoma Compound
Provectus Pharmaceuticals Inc., a development-stage biopharmaceutical company engaged in oncology and dermatology, today announced additional positive data from its phase…